These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25149600)

  • 1. Percutaneous radiofrequency ablation of hepatic tumours: factors affecting technical failure of artificial ascites formation using an angiosheath.
    Kang TW; Lee MW; Hye MJ; Song KD; Lim S; Rhim H; Lim HK; Cha DI
    Clin Radiol; 2014 Dec; 69(12):1249-58. PubMed ID: 25149600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience.
    Rhim H; Lim HK; Kim YS; Choi D
    AJR Am J Roentgenol; 2008 Jan; 190(1):91-8. PubMed ID: 18094298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract.
    Kondo Y; Yoshida H; Shiina S; Tateishi R; Teratani T; Omata M
    Br J Surg; 2006 Oct; 93(10):1277-82. PubMed ID: 16783759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous radiofrequency ablation for hepatic tumors abutting the diaphragm: clinical assessment of the heat-sink effect of artificial ascites.
    Nam SY; Rhim H; Kang TW; Lee MW; Kim YS; Choi D; Lee WJ; Park Y; Chang I; Lim HK
    AJR Am J Roentgenol; 2010 Feb; 194(2):W227-31. PubMed ID: 20093579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line radiofrequency ablation with or without artificial ascites for hepatocellular carcinomas in a subcapsular location: local control rate and risk of peritoneal seeding at long-term follow-up.
    Kang TW; Lim HK; Lee MW; Kim YS; Choi D; Rhim H
    Clin Radiol; 2013 Dec; 68(12):e641-51. PubMed ID: 23973161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients.
    Song I; Rhim H; Lim HK; Kim YS; Choi D
    Eur Radiol; 2009 Nov; 19(11):2630-40. PubMed ID: 19557416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidewire-catheter induced hydrodissection to assist radiofrequency ablation for subcapsular hepatocellular carcinoma with iodized oil retention in patients with failed artificial ascites due to perihepatic adhesion.
    Shin SW; Cho SK; Hyun D; Park KB; Park HS; Do YS
    Diagn Interv Radiol; 2021 Nov; 27(6):746-753. PubMed ID: 34792029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-Guided Radiofrequency Ablation Using a New Electrode with an Electromagnetic Position Sensor for Hepatic Tumors Difficult to Place an Electrode: A Preliminary Clinical Study.
    Kang TW; Lee MW; Song KD; Rhim H; Lim HK; Kang W; Kim K
    Cardiovasc Intervent Radiol; 2017 Dec; 40(12):1891-1898. PubMed ID: 28726002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous thermal ablation of hepatic tumors: local control efficacy and risk factors for artificial ascites failure.
    Zhuang BW; Xie XH; Yang DP; Lin MX; Wang W; Lu MD; Kuang M; Xie XY
    Int J Hyperthermia; 2021; 38(1):461-470. PubMed ID: 33752538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of artificial ascites to assist thermal ablation of liver cancer adjacent to the gastrointestinal tract in patients with previous abdominal surgery.
    Huang Q; Li J; Zeng Q; Tan L; Zheng R; He X; Li K
    BMC Cancer; 2020 Aug; 20(1):763. PubMed ID: 32795279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomographic-guided percutaneous radiofrequency ablation with hydrodissection of hepatic malignancies in the subcapsular location: Evaluation of safety and technical efficacy.
    Liu CH; Yu CY; Chang WC; Dai MS; Hsiao CW; Chou YC; Huang GS
    J Chin Med Assoc; 2016 Feb; 79(2):93-100. PubMed ID: 26507775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography.
    Park HJ; Lee MW; Rhim H; Cha DI; Kang TW; Lim S; Song KD; Lim HK
    Clin Radiol; 2015 Apr; 70(4):387-94. PubMed ID: 25582889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma].
    Li ZR; Kang Z; Qian JS; Zhu KS; Jiang ZB; Huang MS; Guan SH; Shan H
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1749-51. PubMed ID: 18024306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid-term outcome of positron emission tomography/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumours--a single-centre experience.
    Kuehl H; Stattaus J; Hertel S; Hunold P; Kaiser G; Bockisch A; Forsting M
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):234-40. PubMed ID: 18155453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation alone versus radiofrequency ablation combined with chemoembolization in unresectable hepatocellular carcinoma.
    Siriapisith T; Siwasattayanon P; Tongdee T
    J Med Assoc Thai; 2012 Mar; 95(3):430-6. PubMed ID: 22550844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract.
    Zhang M; Liang P; Cheng ZG; Yu XL; Han ZY; Yu J
    Int J Hyperthermia; 2014 Mar; 30(2):134-41. PubMed ID: 24571176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinoma.
    Wang CC; Kao JH
    Hepatol Int; 2015 Oct; 9(4):514-9. PubMed ID: 26108302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.